The actin filament-associated
protein AFAP-110 is an actin cross-linking
protein first identified as a substrate of the viral oncogene v-Src.
AFAP-110 regulates actin cytoskeleton integrity but also functions as an adaptor
protein that affects crosstalk between Src and PKC. Here we investigated the roles of
AFAP-110 in the tumorigenic process of prostate
carcinoma. Using immunohistochemistry of human tissue arrays, we found that
AFAP-110 was absent or expressed at very low levels in normal prostatic epithelium and
benign prostatic hyperplasia but significantly increased in prostate
carcinomas. The level of
AFAP-110 in
carcinomas correlated with the Gleason scores. Downregulation of
AFAP-110 in PC3
prostate cancer cells inhibited cell proliferation in vitro and tumorigenicity and growth in orthotopic nude mouse models. Furthermore, downmodulation of
AFAP-110 resulted in decreased cell-matrix adhesion and cell migration, defective focal adhesions, and reduced
integrin beta1 expression. Reintroduction of avian
AFAP-110 or a mutant disabling its interaction with Src restored these properties. However, expression of an
AFAP-110 lacking the PKC-interacting domain failed to restore properties of parental cells. Thus, increased expression of
AFAP-110 is associated with progressive stages of
prostate cancer and is critical for tumorigenic growth, in part by regulating focal contacts in a PKC-dependent mechanism.